From: Egyptian guidelines for the treatment of Rheumatoid Arthritis — 2022 update
Level of evidence | |
1a 1b 1c | SR (with homogeneity∗) of RCTs Individual RCT (with narrow confidence interval) All or none |
2a 2b 2c | SR (with homogeneity∗) of cohort studies Individual cohort study (including low-quality RCT, e.g. < 80% follow-up) ‘Outcomes’ research; ecological studies |
3a 3b | SR (with homogeneity∗) of case-control studies Individual case-control study |
4 | Case series (and poor-quality cohort and case-control studies) |
5 | Expert opinion without explicit critical appraisal or based on physiology, bench research, or ‘first principles’ |
Grades of recommendation | |
A | Consistent level 1 studies |
B | Consistent levels 2 or 3 studies or extrapolations from level 1 studies |
C | Level 4 studies or extrapolations from levels 2 or 3 studies |
D | Level 5 evidence or troubling, inconsistent, or inconclusive studies of any level |